Chyron CHYR shares dipped 15.38% to $0.88 at 9:50 am. Chyron's trailing-twelve-month ROE is -11.24%.
Telik TELK dropped 14.43% to $2.55. Telik has been granted orphan drug designation by the US FDA for the treatment of myelodysplastic syndrome.
hhgregg HGG shares lost 10.52% to $7.06. hhgregg expects around 3.6% decline in its FQ3 net sales.
Acasti Pharma ACST fell 10.26% to $2.42. Acasti Pharma's 52-week trading range is $1.21-3.99.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in